| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5655850 | Digestive and Liver Disease | 2017 | 7 Pages |
Abstract
This study supports the use of UDCA as first line therapy in ICP.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Yannick Bacq, Matthieu le Besco, Anne-Isabelle Lecuyer, Chantal Gendrot, Jérôme Potin, Christian R. Andres, Alexandre Aubourg,